Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
As of close of business last night, Fate Therapeutics Inc’s stock clocked out at $1.75, down -6.42% from its previous closing price of $1.87. In other words, the price has decreased by -$6.42 from its previous closing price. On the day, 1.79 million shares were traded. FATE stock price reached its highest trading level at $1.91 during the session, while it also had its lowest trading level at $1.72.
Ratios:
To gain a deeper understanding of FATE’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.29 and its Current Ratio is at 8.29. In the meantime, Its Debt-to-Equity ratio is 0.27 whereas as Long-Term Debt/Eq ratio is at 0.25.
On June 17, 2024, Piper Sandler Upgraded its rating to Overweight which previously was Neutral and also upped its target price recommendation from $4 to $6.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 20 ’24 when Redmile Group, LLC bought 397,964 shares for $1.68 per share. The transaction valued at 668,580 led to the insider holds 12,884,277 shares of the business.
Redmile Group, LLC sold 341,633 shares of FATE for $573,943 on Dec 20 ’24. The Director now owns 12,486,313 shares after completing the transaction at $1.68 per share. On Dec 20 ’24, another insider, Redmile Group, LLC, who serves as the Director, 10% Stockholder of the company, bought 341,633 shares for $1.66 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FATE now has a Market Capitalization of 199314496 and an Enterprise Value of 15040403. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.82 while its Price-to-Book (P/B) ratio in mrq is 0.55. Its current Enterprise Value per Revenue stands at 1.118 whereas that against EBITDA is -0.091.
Stock Price History:
Over the past 52 weeks, FATE has reached a high of $8.83, while it has fallen to a 52-week low of $1.55. The 50-Day Moving Average of the stock is -22.19%, while the 200-Day Moving Average is calculated to be -51.94%.
Shares Statistics:
It appears that FATE traded 2.96M shares on average per day over the past three months and 3254400 shares per day over the past ten days. A total of 113.88M shares are outstanding, with a floating share count of 97.96M. Insiders hold about 13.99% of the company’s shares, while institutions hold 89.18% stake in the company. Shares short for FATE as of 1734048000 were 12186948 with a Short Ratio of 4.12, compared to 1731628800 on 10388854. Therefore, it implies a Short% of Shares Outstanding of 12186948 and a Short% of Float of 12.280000000000001.
